Viscosupplementation Reinvented with Biomimetic Polymers to Restore Mobility in OA Patients

An alarming number of individuals suffering from osteoarthritis (OA) has fueled innovation of next-gen viscosupplements. Companies in the viscosupplementation market are increasing efforts to deliver formulations that result in long-lasting pain relief. For instance, Articulate Biosciences— a pre-seed medical device startup, has gained expertise in the development of next-gen, cartilage-protecting viscosupplement that provides significantly longer pain relief to OA patients. The key to success in the market for viscosupplementation is longer pain relief and restoration of mobility in OA patients. Such innovations are bolstering market growth, where the market is estimated to reach a value of ~US$ 4.8 Bn by the end of 2027.

Novel biomimetic polymer viscosupplements are increasingly replacing in-development osteoarthritis joint injections. Hence, companies in the viscosupplementation market are increasing R&D in biocompatible polymers, since these polymers are extensively used in FDA-approved stents, contact lenses, and surgical meshes. The market is witnessing a change with the introduction of biocompatible polymers that prevent degradation associated with hyaluronic acid.

viscosupplementation market Infographic

To know the scope of our report Get a Sample on Viscosupplementation Market

Intra-articular Single-injection Viscosupplements Enter List of High-value Therapeutic Solutions

Innovations in intra-articular single-injection viscosupplements are generating revenue opportunities for healthcare companies. This is justified since the revenue of single-injection products is predicted to experience an uptick in the viscosupplementation market. Companies are developing viscosupplements that stay for a prolonged period in the knee joint cavity. For instance, Seikagaku Corporation— a Japan-based pharmaceutical company, announced the launch of HyLink®, a CE marked intra-articular single-injection viscosupplement used for the treatment of knee osteoarthritis through MDM S.p.A., a pharmaceutical company involved in active marketing of high-value therapeutic solutions in Italy. As such, the revenue of knee osteoarthritis application segment is projected for exponential growth in the viscosupplementation market.

Get a glimpse of the in-depth analysis through our Report Brochure

Companies in the market for viscosupplementation are increasing their research efforts in cross-linked hyaluronate hydrogel, which stays longer in the knee joint cavity and offers pain relief for prolonged weeks. Manufacturers in the market for viscosupplementation are setting their collaboration wheels in motion by entering into exclusive distributorship agreements to strategically target OA patients.

Consensus-based Expert Statements to Guide Practitioners on IAHA Implementation

The viscosupplementation market is projected to expand at a CAGR of ~7% during the forecast period. Since companies have established a strong business hold in North America, they are now turning toward Asia Pacific to unearth revenue streams, since this market in Asia Pacific is anticipated for aggressive growth. India being one of the rapidly growing economies of Asia Pacific, is grabbing the attention of healthcare companies and researchers to develop products through deep understanding of patients and clinician needs. However, it has been found that there is a dearth of robust evidence supporting the effectiveness of viscosupplementation or intra-articular hyaluronic acid (IAHA) treatment, which is likely to hamper market growth.

Nonoperative treatment approaches such as viscosupplementation and IAHA delay the need for total knee replacement surgeries in patients who are not ideal candidates for invasive treatment methods. However, the lack of clinical evidence on the safety and effectiveness of IAHA has created barriers for market growth in India. Thus, companies in the viscosupplementation market should increase efforts to collect consensus-based expert statements that can guide practitioners on IAHA use.

Combination Therapy of Gel Injection and Knee Bracing Benefit Moderate-grade Knee Arthritis Patients

Apart from knee OA, companies in the viscosupplementation market are seeking value growth by increasing treatment options for hip and hand OA. Manufacturers are increasing their production capabilities to develop innovative synovial fluids that thicken up when pressure is applied and act as shock absorbing materials. The growing availability of synthetic products are triggering the growth of the viscosupplementation market. This is evident since non-animal sourced products are anticipated for exponential growth in the market landscape.

Companies in the market for viscosupplementation are increasing awareness about combination treatments such as gel injections with knee bracing to improve patient outcomes. It has been found that gel injections may be more effective when combined with knee bracing. This combination treatment are benefitting patients with moderate-grade knee arthritis. Likewise, companies are increasing R&D activities to develop combination therapies using stem cell for patients with severe knee arthritis.

viscosupplementation market Segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

Apart from retail pharmacies, companies in the viscosupplementation market are directing their supply chains toward online pharmacies, since this distribution channel is projected for aggressive growth during the forecast period. Companies are focusing on innovations in 3-injection regimens using sodium hyarulonate acid.

IAHA has helped to delay the need for total knee replacement surgeries in patients who are not ideal for surgical treatments. However, the lack of evidence on the safety and effectiveness of IAHA has slowed down market growth. Hence, companies should aim toward collecting consensus-based expert statements through government-held advisory board meetings that can guide practitioners on the IAHA use.

Viscosupplementation Market: Overview

  • Viscosupplement drugs can be administered using single injection, three injections, and five injections. These injections are used for arthritis for all types of joint.
  • In this procedure, a gel-like fluid called hyaluronic acid is injected into the joint
  • The three injections segment dominated the global viscosupplementation market in 2018. Growth of the segment can be attributed to increase in demand for viscosupplement injections and rise in adoption of this therapy.
  • Rise in prevalence of osteoarthritis among the geriatric population is a major factor boosting the growth of the global viscosupplementation market. The prevalence of osteoarthritis is high among the elderly population and increases with age. An article published by the Geriatric Orthopedic Surgery & Rehabilitation in 2015 stated that osteoarthritis (OA) is the most common age-related joint disease affecting over 80% people aged above 55.
  • Surge in demand for minimally invasive surgery is another factor fueling the growth of the global viscosupplementation market. Viscosupplement injection is a minimally invasive therapy for osteoarthritis, which minimizes blood loss, reduces hospital stay, offers quicker rehabilitation, and smaller incision. Rise in inclination toward minimally invasive surgery drives demand for viscosupplementation.

Rise in Awareness about New Drugs for Treatment

  • Rise in awareness about new drugs for treatment propels the global market. Knee osteoarthritis is a leading cause of disability among the geriatric population. Therapeutic options for knee OA include non-pharmacologic, pharmacologic, and surgical interventions. Joint replacement surgery is generally reserved for patients who do not respond to other treatments. An article published in NCBI in 2015 indicated that treatments considered to be most effective include viscosupplement injections (74.1%), narcotics (67.8%), and steroid injection (67.6%).

Market Segmentation: Viscosupplementation Market

  • Based on product type, the global viscosupplementation market has been divided into single injection, three injections, and five injections
  • In terms of application, the global viscosupplementation market has been classified into knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis
  • Based on source, the global viscosupplementation market has been bifurcated into animal and non-animal
  • In terms of distribution channel, the global viscosupplementation market has been categorized into retail pharmacies, hospital pharmacies, and online pharmacies
  • Each of the segments has been analyzed in detail for market trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027 along with market size estimations.

Geographic Overview: Viscosupplementation Market

  • In terms of region, the global viscosupplementation market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and future market sizes in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2017 to 2027, with their CAGRs for the period from 2019 to 2027
  • The study also offers a list of recommendations, highlights, and useful insights of the market which will help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process

Major Players

  • The report concludes with the company profiles section that includes key information about the major players in the market
  • Leading players analyzed in the report are 
    • Sanofi
    • Anika Therapeutics, Inc.
    • Seikagaku Corporation
    • Zimmer Biomet
    • Ferring B.V.
    • LG Chem
    • Chugai Pharmaceutical Co., Ltd,
    • Bioventus, Inc.
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Viscosupplementation Market - Scope of the Report

TMR’s report on the global viscosupplementation market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the global viscosupplementation market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global viscosupplementation market from 2019 to 2027.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global viscosupplementation market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global viscosupplementation market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global viscosupplementation market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global viscosupplementation market.

The report also delves into the competitive landscape of the global viscosupplementation market. Key players operating in the global viscosupplementation market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global viscosupplementation market that have been profiled in this report.

Key Questions Answered in Viscosupplementation Market Report

  • What is the sales/revenue generated by viscosupplementation across all regions during the forecast period?
  • What are the opportunities in the global viscosupplementation market?
  • What are the major drivers, restraints, opportunities, and threats in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which product segment is expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Viscosupplementation Market - Research Objectives and Research Approach

The comprehensive report on the global viscosupplementation market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global viscosupplementation market in terms of product type, application, source, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global viscosupplementation market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Viscosupplementation Market - Segmentation

TMR’s study on the global viscosupplementation market includes information divided into five segments: product type, source, application, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global viscosupplementation market have been discussed in detail.

Product Type

Single Injection

Three Injections

Five Injections

Application

Knee Osteoarthritis

Hip Osteoarthritis

Hand Osteoarthritis

Source

Animal

Non-animal

Distribution Channel

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Viscosupplementation Market

4. Market Overview

    4.1.  Introduction & Overview

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunities 

    4.3. Porter’s Five Forces Analysis

    4.4. Global Viscosupplementation Market Analysis and Forecast, 2017–2027

5. Market Outlook 

    5.1. Disease Prevalence & Incidence Rate globally with key countries 

    5.2. Key Industry Development 

6. Global Viscosupplementation Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Global Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        6.2.1. Single Injection

        6.2.2. Three Injections

        6.2.3. Five Injections

    6.3. Global Viscosupplementation Market Attractiveness, by Product Type

7. Global Viscosupplementation Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Global Viscosupplementation Market Value (US$) Forecast, by Application, 2017–2027

        7.2.1. Knee Osteoarthritis

        7.2.2. Hip Osteoarthritis

        7.2.3. Hand Osteoarthritis

    7.3. Global Viscosupplementation Market Attractiveness, by Application

8. Global Viscosupplementation Market Analysis and Forecast, by Source

    8.1. Introduction & Definition

    8.2. Global Viscosupplementation Market Value (US$) Forecast, by Source, 2017–2027

        8.2.1. Animal

        8.2.2. Non-animal

    8.3. Global Viscosupplementation Market Attractiveness, by Source

9. Global Viscosupplementation Market Analysis and Forecast, by Distribution Channel

    9.1. Introduction & Definition

    9.2. Global Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        9.2.1. Hospital Pharmacies

        9.2.2. Retail Pharmacies

        9.2.3. Online Pharmacies

    9.3. Global Viscosupplementation Market Attractiveness, by Distribution Channel

10. Global Viscosupplementation Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Global Viscosupplementation Market Value (US$ Mn) Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Global Viscosupplementation Market Attractiveness, by Region

11. North America Viscosupplementation Market Analysis and Forecast

    11.1. Introduction

    11.2. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        11.2.1. Single Injection

        11.2.2. Three Injections

        11.2.3. Five Injections

    11.3. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

        11.3.1. Knee Osteoarthritis

        11.3.2. Hip Osteoarthritis

        11.3.3. Hand Osteoarthritis

    11.4. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

        11.4.1. Animal

        11.4.2. Non-animal

    11.5. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        11.5.1. Hospital Pharmacies

        11.5.2. Retail Pharmacies

        11.5.3. Online Pharmacies

    11.6. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Viscosupplementation Market Attractiveness Analysis

        11.7.1. By Product Type

        11.7.2. By Application

        11.7.3. By Source

        11.7.4. By Distribution Channel

        11.7.5. By Country 

12. Europe Viscosupplementation Market Analysis and Forecast

    12.1. Introduction

    12.2. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        12.2.1. Single Injection

        12.2.2. Three Injections

        12.2.3. Five Injections

    12.3. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

        12.3.1. Knee Osteoarthritis

        12.3.2. Hip Osteoarthritis

        12.3.3. Hand Osteoarthritis

    12.4. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

        12.4.1. Animal

        12.4.2. Non-animal

    12.5. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        12.5.1. Hospital Pharmacies

        12.5.2. Retail Pharmacies

        12.5.3. Online Pharmacies

    12.6. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Viscosupplementation Market Attractiveness Analysis

        12.7.1. By Product Type

        12.7.2. By Application

        12.7.3. By Source

        12.7.4. By Distribution Channel 

        12.7.5. By Country/Sub-region

13. Asia Pacific Viscosupplementation Market Analysis and Forecast

    13.1. Introduction

    13.2. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        13.2.1. Single Injection

        13.2.2. Three Injections

        13.2.3. Five Injections

    13.3. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

        13.3.1. Knee Osteoarthritis

        13.3.2. Hip Osteoarthritis

        13.3.3. Hand Osteoarthritis

    13.4. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

        13.4.1. Animal

        13.4.2. Non-animal

    13.5. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        13.5.1. Hospital Pharmacies

        13.5.2. Retail Pharmacies

        13.5.3. Online Pharmacies

    13.6. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Viscosupplementation Market Attractiveness Analysis

        13.7.1. By Product Type

        13.7.2. By Application

        13.7.3. By Source

        13.7.4. By Distribution Channel 

        13.7.5. By Country/Sub-region

14. Latin America Viscosupplementation Market Analysis and Forecast

    14.1. Introduction

    14.2. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        14.2.1. Single Injection

        14.2.2. Three Injections

        14.2.3. Five Injections

    14.3. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

        14.3.1. Knee Osteoarthritis

        14.3.2. Hip Osteoarthritis

        14.3.3. Hand Osteoarthritis

    14.4. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

        14.4.1. Animal

        14.4.2. Non-animal

    14.5. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        14.5.1. Hospital Pharmacies

        14.5.2. Retail Pharmacies

        14.5.3. Online Pharmacies

    14.6. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Viscosupplementation Market Attractiveness Analysis

        14.7.1. By Product Type

        14.7.2. By Application

        14.7.3. By Source

        14.7.4. By Distribution Channel 

        14.7.5. By Country/Sub-region

15. Middle East & Africa Viscosupplementation Market Analysis and Forecast

    15.1. Introduction

    15.2. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        15.2.1. Single Injection

        15.2.2. Three Injections

        15.2.3. Five Injections

    15.3. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

        15.3.1. Knee Osteoarthritis

        15.3.2. Hip Osteoarthritis

        15.3.3. Hand Osteoarthritis

    15.4. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

        15.4.1. Animal

        15.4.2. Non-animal

    15.5. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        15.5.1. Hospital Pharmacies

        15.5.2. Retail Pharmacies

        15.5.3. Online Pharmacies

    15.6. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Israel

        15.6.4. Rest of Middle East & Africa

    15.7. Middle East & Africa Viscosupplementation Market Attractiveness Analysis

        15.7.1. By Product Type

        15.7.2. By Application

        15.7.3. By Source

        15.7.4. By Distribution Channel 

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Competition Matrix

    16.2. Market Share Analysis, by Company, 2018

    16.3. Company Profiles

        16.3.1. Sanofi 

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Company Financials

            16.3.1.3. Growth Strategies

            16.3.1.4. SWOT Analysis

        16.3.2. Anika Therapeutics, Inc. 

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Company Financials

            16.3.2.3. Growth Strategies

            16.3.2.4. SWOT Analysis

        16.3.3. Zimmer Biomet Holdings, Inc. 

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Company Financials

            16.3.3.3. Growth Strategies

            16.3.3.4. SWOT Analysis

        16.3.4. Ferring B.V. 

            16.3.4.1. Company Overview (HQ, Business Segments)

            16.3.4.2. Growth Strategies

            16.3.4.3. SWOT Analysis

        16.3.5. Chugai Pharmaceutical Co., Limited

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Company Financials

            16.3.5.3. Growth Strategies

            16.3.5.4. SWOT Analysis

        16.3.6. Bioventus, Inc.

            16.3.6.1. Company Overview (HQ, Business Segments)

            16.3.6.2. Growth Strategies

            16.3.6.3. SWOT Analysis

        16.3.7. Labrha International 

            16.3.7.1. Company Overview (HQ, Business Segments)

            16.3.7.2. Growth Strategies

            16.3.7.3. SWOT Analysis

        16.3.8. Seikagaku Corporation 

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Company Financials

            16.3.8.3. Growth Strategies

            16.3.8.4. SWOT Analysis

        16.3.9. LG Chem 

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Company Financials

            16.3.9.3. Growth Strategies

            16.3.9.4. SWOT Analysis

List of Tables

Table 01: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 02: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 03: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

Table 04: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 05: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 07: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 08: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

Table 09: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 10: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 11: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 12: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 13: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

Table 14: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 17: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 18: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

Table 19: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 20: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 22: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 23: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

Table 24: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 25: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 27: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 28: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

Table 29: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 30: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

List of Figures

Figure 01: Global Viscosupplementation Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Viscosupplementation Market Value (US$ Mn) Forecast, 2017–2027

Figure 03: Global Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 04: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Single Injection, 2017–2027

Figure 05: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Three Injections, 2017–2027

Figure 06: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Five Injections, 2017–2027

Figure 07: Global Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

Figure 08: Global Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

Figure 09: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Knee Osteoarthritis, 2017–2027

Figure 10: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hip Osteoarthritis, 2017–2027

Figure 11: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hand Osteoarthritis, 2017–2027

Figure 12: Global Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

Figure 13: Global Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

Figure 14: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Animal, 2017–2027

Figure 15: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Non-animal, 2017–2027

Figure 16: Global Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

Figure 17: Global Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 18: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017–2027

Figure 19: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017–2027

Figure 20: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017–2027

Figure 21: Global Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 22: Global Viscosupplementation Market Value Share Analysis, by Region, 2018 and 2027

Figure 23: Global Viscosupplementation Market Attractiveness Analysis, by Region, 2019–2027

Figure 24: North America Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 25: North America Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 26: North America Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

Figure 27: North America Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

Figure 28: North America Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

Figure 29: North America Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

Figure 30: North America Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

Figure 31: North America Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 32: North America Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 33: North America Viscosupplementation Market Value Share Analysis, by Country, 2018 and 2027

Figure 34: North America Viscosupplementation Market Attractiveness Analysis, by Country, 2019–2027

Figure 35: Europe Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 36: Europe Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 37: Europe Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

Figure 38: Europe Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

Figure 39: Europe Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

Figure 40: Europe Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

Figure 41: Europe Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

Figure 42: Europe Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 43: Europe Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 44: Europe Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 45: Europe Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 46: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 47: Asia Pacific Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 48: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

Figure 49: Asia Pacific Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

Figure 50: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

Figure 51: Asia Pacific Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

Figure 52: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

Figure 53: Asia Pacific Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 54: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 55: Asia Pacific Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 56: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 57: Latin America Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 58: Latin America Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 59: Latin America Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

Figure 60: Latin America Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

Figure 61: Latin America Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

Figure 62: Latin America Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

Figure 63: Latin America Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

Figure 64: Latin America Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 65: Latin America Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 66: Latin America Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 67: Latin America Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 68: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 69: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 70: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

Figure 71: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

Figure 72: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

Figure 73: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

Figure 74: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

Figure 75: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 76: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 77: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 78: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027 

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Viscosupplementation Market